Patent details

EP3353304 Title: VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE

Basic Information

Publication number:
EP3353304
PCT Application Number:
US2016053629
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168498327
PCT Publication Number:
WO2017053923
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE
French Title of Invention:
TRAITEMENT DE LA CONJONCTIVITE VIRALE À L'AIDE DE LA RANPIRNASE
German Title of Invention:
BEHANDLUNG VON VIRALER KONJUNKTIVITIS MIT RANPIRNASE
SPC Number:

Dates

Filing date:
25/09/2016
Grant date:
19/10/2022
EP Publication Date:
01/08/2018
PCT Publication Date:
30/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/10/2022
EP B1 Publication Date:
19/10/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/09/2023
Expiration date:
25/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/10/2022
 
 

Name:
Okogen, Inc.
Address:
332 Encinitas Blvd., Suite 102, Encinitas, CA 92024, United States (US)

Inventor

Name:
STREM, Brian
Address:
United States (US)

Priority

Priority Number:
201562233267 P
Priority Date:
25/09/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/46; C12N 15/113; A61K 9/00; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
202242
Publication date:
19/10/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages